Juliana Oliveira

Juliana Oliveira currently serves as the Global Executive Medical Director for Endocrinology at Amgen since August 2024. Prior to this role, Juliana held various leadership positions, including Vice-President of Medical and Scientific Affairs and US Chief Medical Officer at Vifor Pharma from 2021 to October 2023, and Vice President of Clinical Development at Viking Therapeutics, Inc. from 2020 to 2021. Juliana was also Vice-President Global Project Head for Diabetes Development at Sanofi from 2016 to 2020 and Senior Medical Director at Takeda Pharmaceuticals between 2013 and 2016. Earlier experience includes several key roles at Eli Lilly and Company from 2002 to 2013, where Juliana advanced from Clinical Research Physician in Brazil to Diabetes Medical Leader for the Emerging Markets Business Unit. Juliana's educational background includes a Doctor of Philosophy (Ph.D.) in Endocrinology from the Federal University of Sao Paulo, a residency in Internal Medicine from the State University of Campinas-SP, and a Doctor of Medicine (M.D.) from the Federal University Juiz de Fora.